Sunday, October 4, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $333.69 +1.02%
MSFT $517.53 +0.92%
GOOGL $343.50 +1.56%
AMZN $251.52 +1.33%
TSLA $370.59 +4.65%
META $728.08 +0.30%
NVDA $233.95 +1.34%
JPM $332.38 -0.24%
BTC $37.25 -0.51%
ETH $25.46 -1.24%
AAPL
$333.69
▲ 1.02%
MSFT
$517.53
▲ 0.92%
GOOGL
$343.50
▲ 1.56%
AMZN
$251.52
▲ 1.33%
TSLA
$370.59
▲ 4.65%
META
$728.08
▲ 0.30%
NVDA
$233.95
▲ 1.34%
JPM
$332.38
▼ 0.24%
Bloomberg Markets
A dramatic turnaround in technology stocks has powered a $3.5 trillion increase in the Nasdaq 100’s market capitalization in just four days, driven by strong earnings that have emboldened investors about the AI outlook.
business  Aug 5, 2026
Bloomberg Markets
Novo Nordisk Chief Executive Officer Mike Doustdar says the profitability of its popular Wegovy weight-loss pill is "decent" and will continue to improve. "If that was not the case, we would not be launching the product in more and more markets," he tells Bloomberg Television. (Source: Bloomberg)
business  Aug 5, 2026
Bloomberg Markets
Novo Nordisk A/S Chief Executive Officer Mike Doustdar talks about the company's performance as its popular Wegovy weight-loss pill disappointed investors with sales that failed to live up to the hype. "We are not right now discussing further discounts," Doustdar tells Bloomberg's Francine Lacqua. (Source: Bloomberg)
business  Aug 5, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free